Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5- d ]azepines as Potent 5-Hydroxytryptamine 2C (5-HT 2C ) Receptor Agonists with Exquisite Functional Selectivity over 5-HT 2A and 5-HT 2B Receptors
R. Ian Storer, Paul E. Brennan, Alan D. Brown et al. · Journal of Medicinal Chemistry · 2014
A series of 4-substituted pyrimido[4,5-d]azepines that are potent, selective 5-HT2C receptor partial agonists is described. A rational medicinal chemistry design strategy to deliver CNS penetration coupled with SAR-based optimization of selectivity and agonist potency provided compounds with the desired balance of preclinical properties. Lead compounds 17 (PF-4479745) and 18 (PF-4522654) displayed robust pharmacology in a preclinical canine model of stress urinary incontinence (SUI) and no measurable functional agonism at the key selectivity targets 5-HT2A and 5-HT2B in relevant tissue-based assay systems. Utilizing recent advances in the structural biology of GPCRs, homology modeling has been carried out to rationalize binding and agonist efficacy of these compounds.
Cited by 37 works. doi:10.1021/jm5003292
Authors
- Paul E. Brennan
- Alan D. Brown
- Peter J. Bungay
- Kelly M. Conlon
- Matthew S. Corbett
- Robert P. DePianta
- Paul V. Fish
- Alexander Heifetz
- Danny K. H. Ho
- Alan S. Jessiman
- Gordon McMurray
- César Augusto F. de Oliveira
- Lee R. Roberts
- James A. Root
- Veerabahu Shanmugasundaram
- Michael J. Shapiro
- Melanie Skerten
- Dominique Westbrook
- Simon Wheeler
References
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
- High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
- Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin
- Hallucinogens
- P-Glycoprotein, a gatekeeper in the blood–brain barrier
- Estimation of Blood-Brain Barrier Crossing of Drugs Using Molecular Size and Shape, and H-Bonding Descriptors
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
- Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs
- Drugs and Valvular Heart Disease